The CITRE® Company, an international presence in Seville, Spain, represents a major investment by Celgene Corporation in cutting-edge technology in Europe.

CITRE®

innovation and collaboration to meet the medical challenges of the 21st century

CITRE®, the Celgene Institute of Translational Research Europe, is a focal point for advanced biomedical research including regenerative medicine, personalized medicine and cellular therapies.

CITRE consists of five departments - tumor biobanking, bioinformatics, placental stem cells, epigenetics and cell signaling. They will be supported by five services - cell culture, cytometry, electronic microscopy, genomics and proteomics, organized around a Central Unit for Translational Medical Research.

Located in Seville, Spain, CITRE grows out of a shared vision between Celgene and the government of Andalusia to provide a bridge between the discoveries of basic research and their application in addressing the needs of modern medicine.